Palmivax
Palmivax
Authorised
- Derzsy's disease virus, strain Hoekstra, Live
Product identification
Medicine name:
Palmivax
Active substance:
- Derzsy's disease virus, strain Hoekstra, Live
Target species:
-
Goose
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Derzsy's disease virus, strain Hoekstra, Live316.23/tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Goose
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01DD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 44a/83
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 5/04/2022
How useful was this page?:
